S Nakamori

850 total citations
19 papers, 726 citations indexed

About

S Nakamori is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, S Nakamori has authored 19 papers receiving a total of 726 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Molecular Biology and 4 papers in Surgery. Recurrent topics in S Nakamori's work include Pancreatic and Hepatic Oncology Research (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers) and Cancer Genomics and Diagnostics (3 papers). S Nakamori is often cited by papers focused on Pancreatic and Hepatic Oncology Research (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers) and Cancer Genomics and Diagnostics (3 papers). S Nakamori collaborates with scholars based in Japan and United States. S Nakamori's co-authors include Susumu Imaoka, T Kabuto, Masao Kameyama, Hiroshi Furukawa, Yosuke Matsushita, Yo Sasaki, Tatsuro Irimura, Yusuke Nakamura, Takashi Kanematsu and Yasuhiro Fujiwara and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and British Journal of Cancer.

In The Last Decade

S Nakamori

19 papers receiving 714 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S Nakamori Japan 9 462 274 183 135 108 19 726
Tatsuro Irimura Japan 8 470 1.0× 165 0.6× 244 1.3× 126 0.9× 115 1.1× 8 623
Tetsuji Sawada Japan 20 494 1.1× 392 1.4× 220 1.2× 58 0.4× 89 0.8× 38 928
M. L. Hanski Germany 8 867 1.9× 269 1.0× 142 0.8× 47 0.3× 73 0.7× 12 1.1k
D. Fan United States 14 404 0.9× 359 1.3× 97 0.5× 68 0.5× 128 1.2× 23 804
Iwao Ohizumi Japan 13 392 0.8× 154 0.6× 126 0.7× 43 0.3× 136 1.3× 23 729
D. J. Ruiter Netherlands 10 300 0.6× 287 1.0× 274 1.5× 73 0.5× 141 1.3× 13 763
Melissa C. Thompson United States 6 590 1.3× 273 1.0× 173 0.9× 28 0.2× 222 2.1× 7 759
Yun Oh United States 18 561 1.2× 373 1.4× 115 0.6× 55 0.4× 46 0.4× 28 1.0k
Stuart D. Hoff United States 6 291 0.6× 116 0.4× 114 0.6× 89 0.7× 103 1.0× 6 413
Liancheng Zhu China 20 657 1.4× 226 0.8× 238 1.3× 48 0.4× 79 0.7× 72 1.1k

Countries citing papers authored by S Nakamori

Since Specialization
Citations

This map shows the geographic impact of S Nakamori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Nakamori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Nakamori more than expected).

Fields of papers citing papers by S Nakamori

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Nakamori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Nakamori. The network helps show where S Nakamori may publish in the future.

Co-authorship network of co-authors of S Nakamori

This figure shows the co-authorship network connecting the top 25 collaborators of S Nakamori. A scholar is included among the top collaborators of S Nakamori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Nakamori. S Nakamori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Kurokawa, Yukinori, Ryo Matoba, S Nakamori, et al.. (2004). PCR-array gene expression profiling of hepatocellular carcinoma.. PubMed. 23(1). 135–41. 32 indexed citations
2.
Nakamori, S, et al.. (2004). Neoadjuvant chemoradiation therapy with gemcitabine and accelerated hyperfractionaed radiation for potentially resectable pancreatic cancer: A dose-finding study. Journal of Clinical Oncology. 22(14_suppl). 4217–4217. 3 indexed citations
3.
Okami, Jiro, S Nakamori, Hajime Yamamoto, et al.. (2002). An immunohistochemical study of cyclooxygenase (COX)-2 expression in endocrine tumors of the pancreas.. PubMed. 21(4). 569–76. 8 indexed citations
4.
Yamamoto, Takuo, Hiroaki Nagano, Masahiro Kondo, et al.. (2001). [A patient with hepatocellular carcinoma and portal vein thrombosis in 1st branch who was treated by transcatheter arterial embolization].. PubMed. 28(11). 1718–23. 1 indexed citations
5.
Yamamoto, Hirokazu, Yasuhiro Miyake, S. Noura, et al.. (2001). [Clinical significance of micrometastasis to lymph nodes in gastrointestinal tract cancers].. PubMed. 28(6). 776–83. 5 indexed citations
6.
Okamoto, Hirotaka, Hiroaki Ohigashi, S Nakamori, et al.. (2000). Reciprocal Functions of Liver Tumor Cells and Endothelial Cells. European Surgical Research. 32(6). 374–379. 5 indexed citations
7.
Okami, Jiro, Masato Sakon, Kyoko Iwao, et al.. (2000). Genetic detection for micrometastasis in lymph node of biliary tract carcinoma.. PubMed. 6(6). 2326–32. 42 indexed citations
8.
Bilchik, Anton J., Mark R. Kelley, Christine Kuo, et al.. (2000). Molecular detection of metastatic pancreatic carcinoma cells using a multimarker reverse transcriptase-polymerase chain reaction assay. Cancer. 88(5). 1037–1044. 29 indexed citations
9.
Yamada, Tomonori, S Nakamori, Hiroki Ohzato, et al.. (2000). Outcome of pancreatic cancer patients based on genetic lymph node staging.. International Journal of Oncology. 16(6). 1165–71. 9 indexed citations
10.
Grochowiecki, Tadeusz, Mitsukazu Gotoh, Keizo Dono, et al.. (1999). Pretreatment of islets with mitomycin C and blockage of costimulatory signal induces unresponsiveness to islet xenografts. Transplantation Proceedings. 31(1-2). 925–925. 1 indexed citations
11.
Daigo, Yataro, Yoichi Furukawa, Manabu Fujita, et al.. (1999). Absence of genetic alteration at codon 531 of the human c-src gene in 479 advanced colorectal cancers from Japanese and Caucasian patients.. PubMed. 59(17). 4222–4. 40 indexed citations
12.
Ishikawa, Osamu, Hiroaki Ohigashi, Susumu Imaoka, et al.. (1998). Regional chemotherapy to prevent hepatic metastasis after resection of pancreatic cancer.. PubMed. 44(18). 1541–6. 23 indexed citations
13.
Kuroki, Tamotsu, Yasuhiro Fujiwara, S Nakamori, et al.. (1995). Evidence for the presence of two tumour-suppressor genes for hepatocellular carcinoma on chromosome 13q. British Journal of Cancer. 72(2). 383–385. 59 indexed citations
14.
Nakano, Hiroshi, Yo Sasaki, Susumu Imaoka, et al.. (1994). [A case of hepatocellular carcinoma implantation to chest wall by percutaneous ethanol injection therapy].. PubMed. 21(13). 2350–3. 2 indexed citations
15.
Sasai, H, Tatsuya Higashi, S Nakamori, et al.. (1993). Syrian hamster embryo cell lines useful for detecting transforming genes in mouse tumours: detection of transforming genes in X-ray-related mouse tumours. British Journal of Cancer. 67(2). 262–267. 6 indexed citations
16.
Irimura, Tatsuro, S Nakamori, Yukiyo Matsushita, et al.. (1993). Colorectal cancer metastasis determined by carbohydrate-mediated cell adhesion: role of sialyl-LeX antigens.. PubMed. 4(5). 319–24. 81 indexed citations
17.
Nakamori, S, Masao Kameyama, Susumu Imaoka, et al.. (1993). Increased expression of sialyl Lewisx antigen correlates with poor survival in patients with colorectal carcinoma: clinicopathological and immunohistochemical study.. PubMed. 53(15). 3632–7. 376 indexed citations
18.
Nakamori, S, T. Enomoto, Hideki Hayashi, et al.. (1989). Protein kinase C activation in a 3T3 cell variant morphologically unresponsive to tumor-promoting phorbol esters.. PubMed. 19(6). 1419–26. 2 indexed citations
19.
Nakamori, S. (1971). [Electron microscopic studies on the innervation muscles of the esophagus, trachea and bronchus of the guinea pig].. PubMed. 74(6). 1040–5. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026